Although animal models used to study host tumor interactions do not extrapolate ideally to the clinical setting, they have provided important and useful information about glutamine metabolism and its regulation in malignant disease. These studies have also served as the basis for initiating the few studies in humans that have been published. There are few clinical trials evaluating the potential benefits of glutamine-enriched nutrition in patients with cancer,